Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Labeling Rule Dies In Latest Reg Agenda, But Electronic Labeling Is Reborn

Dec 15 2017

• By Derrick Gingery

RulesRegulationsBooks_1200x675

Related Content

Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing

Feb 21 2015

BLAs More Appealing As 'Transition' NDAs, ANDAs Set To Lose Exclusivity

Mar 21 2016

Antimicrobial Sponsors Should Update Labels Within Year Of Breakpoint Webpage Launch, US FDA Says

Dec 13 2017

Generic Labeling Rule Defies Predictions, Remains In FDA's Long-Term Pipeline

Jul 26 2017

US Patient Medical Information Rule: Will It Be Delayed Again?

Mar 02 2017

Will Antimicrobial Breakpoint Changes Signal Shift To Online Labeling Updates?

Dec 05 2017

Sanofi's Admelog, a Humalog Follow-On, Approved In US As 'Black Hole' For Insulins Looms

Dec 11 2017

Electronic Prescribing Information: Proposed Rule May Not Completely Eliminate Paper

Dec 16 2014

US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order

Feb 10 2017

Related Companies

Sanofi

Additional Topics

United States Regulation FDA Generic Drugs Biologics BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window